Trusted Partnerships

Partnerships for Success

Ryan Lee

Samsung Biologics

Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

Down Stream Processing

Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines

Songyoung Kim

Samsung Biologics

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Bispecific Antibodies

Accelerating the Development and Production of High-Quality Bispecific Antibodies

Dongyoung Park

Samsung Biologics

Drug Development

Podcast: Insights from CDO Experts from Samsung Biologics

Jiyeon Lee; Hyelyoung Jang

Samsung Biologics

Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

Glycosylation

S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach

Junyong Park

Samsung Biologics

Supply Chain

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Tim Tyson; Jesse McCool, Ph.D.; Russell Harris; Yongkwan Ma

TriRx Pharmaceutical Services

Antibody-Drug Conjugates

Reducing ADC Development Timelines with Integrated Development and Manufacturing Services

Thomas Rohrer

Samsung Biologics

Strategic Partnership

Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies

Samsung Biologics

Aseptic Fill/Finish

Webinar: Capitalizing on CDMO Expertise in Aseptic Fill/Finish, Presented by Samsung Biologics

Samsung Biologics

CDMO Partnerships

Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics

Samsung Biologics

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

CDMO Partnerships

Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market

Daniel Buckley

Samsung Biologics

New Biomanufacturing Facility

Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion

Samsung Biologics